LeonaBio, Inc. (LONA) Earnings History
Net Loss8 years of earnings data (2018–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
LeonaBio, Inc. (LONA) Earnings Overview
As of November 8, 2026, LeonaBio, Inc. (LONA) reported trailing twelve-month net income of -$141M, reflecting +2.0% year-over-year growth. The company earned $-33.08 per diluted share over the past four quarters.
Looking at the long-term picture, LONA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$5M in fiscal 2018.
LeonaBio, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including FLNA (-$42M net income), ACIU (-$36M net income, -1971.6% margin), PRAX (-$339M net income), LONA has comparable earnings metrics. Compare LONA vs FLNA →
LONA Earnings vs Peers
Earnings metrics vs comparable public companies
LONA Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$106M | -8.9% | -$102M | $-24.70 | - | - |
| 2024 | -$97M | +17.6% | -$101M | $-25.20 | - | - |
| 2023 | -$118M | -23.0% | -$125M | $-30.90 | - | - |
| 2022 | -$96M | -74.4% | -$104M | $-25.30 | - | - |
| 2021 | -$55M | -174.9% | -$64M | $-14.90 | - | - |
| 2020 | -$20M | -286.6% | -$20M | $-6.10 | - | - |
| 2019 | -$5M | -1.3% | -$5M | $-1.40 | - | - |
| 2018 | -$5M | - | -$5M | $-1.60 | - | - |
Download Data
Export LONA earnings history in CSV or JSON format
Free sign-in required to download data
LONA Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
8+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
LONA — Frequently Asked Questions
Quick answers to the most common questions about buying LONA stock.
What is LONA earnings per share (EPS)?
LONA trailing twelve-month (TTM) diluted EPS is $-33.08, reflecting +2.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2018 to 2025 is available in the table on this page.
What is LeonaBio, Inc.'s net income?
LeonaBio, Inc. (LONA) trailing twelve-month net income is $-141M as of 2025. Earnings grew +2.0% year-over-year.
Is LONA profitable?
LONA is not currently profitable on a TTM basis, reporting a net loss of $-141M. Net margin is N/A. Investors should monitor for a return to profitability.
What is LONA's earnings growth rate?
LONA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2018 to 2025.
What are LONA's profit margins?
LeonaBio, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -290.8%.
Is LONA growing earnings?
LONA earnings growth is slowing. Current YoY EPS growth of +2.0% trails the 5-year CAGR of N/A. TTM net income is $-141M.
What was LONA's best earnings year?
LeonaBio, Inc.'s highest annual net income on record is $-5M, achieved in fiscal year 2018. Earnings history on this page spans 2018 to 2025 and includes all annual and quarterly figures.
What were LONA's earnings last quarter?
LONA's most recent reported quarter was Q2 2026. Net income was $-19M with diluted EPS of $-4.45. For a full breakdown of all quarters, see the quarterly earnings table on this page.